Wellspect HealthCare has introduced the Surity™ Urinary Management System in the US, completing its portfolio of external catheters for urinary incontinence. This new device offers a discreet, quiet, and user-friendly solution designed to integrate into daily and nighttime routines, helping individuals and caregivers manage severe urinary incontinence at home. The system uses gentle suction with an on-demand boost and carbon filters to reduce odors, aiming to improve comfort, confidence, and rest. It is now available for home purchase and will soon be offered to healthcare institutions.
Target reported stronger-than-expected Q2 results with sales up 5.3% to $26.54 billion and adjusted EPS rising 20% excluding tariff refunds. Digital sales grew 8.7%, driven by same-day delivery, and all core merchandise categories saw sales increases...
ReElement Technologies, partly owned by American Resources Corp, has obtained a Minor Source air permit for its Marion, Indiana Supersite, allowing all planned production lines to operate. This permit is a key step before the facility can begin equip...
Jefferies maintains a 'buy' rating on Diageo with a 2,200p price target, signaling about 30% upside from current levels. The latest annual report reveals a strategic shift from focusing on single brands like Guinness to a broader portfolio approach, ...
Acadia Healthcare (ACHC) is rated a BUY due to its robust capacity expansion pipeline and the increasing demand for mental health services in the US. As the largest independent behavioral healthcare provider with 279 facilities and 12,600 beds, ACHC ...
Stocks declined for a third consecutive session on August 18, driven mainly by weakness in semiconductor stocks, which have been key to the recent market rally. Despite the S&P 500 staying near record highs, concerns over rising Treasury yields, pers...
